Major histocompatibility complex class II region confers susceptibility to Staphylococcus aureus arthritis

Scandinavian Journal of Immunology

Volumn 45, Issue 3, 1997, Pages 301-307

  Abdelnour, A ^a   Zhao, Yi Xue ^a   Holmdahl, R ^b   Tarkowski, A ^a,c  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c Depts Rheumatology Clin Immunol   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; STAPHYLOCOCCUS ENTEROTOXIN; TOXIC SHOCK SYNDROME TOXIN 1; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTHRITIS; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DISEASE PREDISPOSITION; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

EID: 0031044497     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1997.d01-401.x     Document Type: Article

References (28)

1. Nepon GT, Ehrlich H. MHC class II molecules and autoimmunity. Annu Rev Immunol 1991;9:493-525.
2. von Boehmer H, Kisielow P. Self-nonself discrimination by T cells. Science 1990;248:1369-73.
3. Bremell T, Lange S, Yacoub A, Rydén C, Tarkowski A. Experimental Staphylococcus aureus arthritis in mice. Infect Immun 1991;59:2615-23.
4. Bremell T, Abdelnour A, Tarkowski A. Histopathological and serological progression of experimental Staphylococcus aureus arthritis. Infect Immun 1992;60:2976-85.
5. Abdelnour A, Bremell T, Holmdahl R, Tarkowski A. Oligoclonal expansion of T lymphocytes causes arthritis and mortality in mice infected with toxic shock syndrome toxin-1 producing staphylococci. Eur J Immunol 1994;24:1161-6.
6. Cosgrove D, Gray D, Dierich A et al. Mice lacking MHC class II molecules. Cell 1991;66:1051-66.
7. Abdelnour A, Bremell T, Tarkowski A. Toxic shock syndrome toxin-1 contributes to the arthritogenicity of Staphylococcus aureus. J Infect Dis 1994;170:94-9.
8. Jonsson R, Tarkowski A, Klareskog L. A demineralization procedure for immunohistopathological use: EDTA treatment preserves lymphoid cell surface antigens. J Immunol Meth 1986;88:109-14.
9. Springer T, Galfré G, Secher D, Milstein C. Mac-1: a macrophage differentiation antigen identified by monoclonal antibody. Eur J Immunol 1979;9:301-6.
10. Dialynas D, Quan Z, Wall K et al. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal GK 1.5: similarity of L3T4 to the human Leu 3/T4 molecule. J Immunol 1983;131:2445-51.
11. Ledbetter J, Herzenberg L. Xenogenic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol Rev 1979;47:63-90.
12. Acha-Orbea H, Zinkernagel R, Hengartner H. Cytotoxic T cell clone specific monoclonal antibodies used to select clonotypic antigen-specific cytotoxic T cells. Eur J Immunol 1985;15:31-6.
13. Haskins K, Hannum J, White J et al. The major histocompatibility complex-restricted antigen receptor on T cells. VI. An antibody to a receptor allotype. J Exp Med 1984;160:452-71.
14. Pullen A, Marrack P, Kappler J. The T cell repertoire is heavily influenced by tolerance to polymorphic self antigens. Nature 1988;335:796-801.
15. McMaster W, Williams A. Monoclonal antibodies to Ia antigens from rat thymus. Crossreactions with mouse and human and use in purification of rat Ia glycoproteins. Immunol Rev 1979;47:117-35.
16. Abdelnour A, Tarkowski A. Polyclonal B cell activation by an arthritogenic Staphylococcus aureus strain: contribution of T cells and monokines. Cell Immunol 1993;147:279-93.
17. Espevik T, Nissen-Meyer J. A high sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods 1986;95:99-105.
18. Helle M, Boeije L, Aarden L. Functional discrimination betwen interleukin 6 and interleukin 1. Eur J Immunol. 1988;18:1525-40.
19. Farrar M, Schreiber R. The molecular cell biology of interferon-γ and its receptor. Annu Rev Immunol 1993;11:571-611.
20. Zhao Y-X, Tarkowski A. Impact of IFNγ receptor deficiency on experimental Staphylococcus aureus septicemia and arthritis. J Immunol 1995;155:5736-42.
21. Hormaeche C, Harrington K, Joysey H. Natural resistence to Salmonellae in mice: control by genes within the major histocompatibility complex. J Infect Dis 1985;152:1050-6.
22. Marrack P, Kappler J. The staphylococcal enterotoxins and their relatives. Science 1990;248:705-11.
23. Mollick J, Chintagumpala M, Cook R, Rich R. The staphylococcal enterotoxin activation of T cells. Role of exotoxin-MHC class II binding affinity and class II isotypes. J Immunol 1991;146:463-8.
24. Uchiyama T, Tadakuma T, Imanishi K et al. Activation of murine T cells by toxic shock syndrome toxin-1. The toxin-binding structure expressed on murine accessory cells are MHC class II molecules. J Immunol 1989;143:3175-82.
25. Scholl P, Diez A, Sekaly R, Glimcher L, Geha S. Binding of toxic shock syndrome toxin-1 to murine MHC class II molecules. Eur J Immunol 1990;20:1911-16.
26. Green J, Schotland S, Sella Z, Kleeman C. Interleukin-6 attenuates agonist-mediate calcium mobilization in murine osteoblastic cells. J Clin Invest 1994;93:2340-50.
27. Saéz-LLorens X, Jafari H, Olsen K, Nariuchi H, Hansen E, MacCraken G. Induction of suppurative arthritis in rabbits by Heamophilus endotoxin, tumor necrosis factor-alpha, and interleukin-1beta. J Infect Dis 1991;163:1267-72.
28. Jacob CO, McDevitt HO. Tumour necrosis factor-alpha in murine autoimmune 'lupus' nephritis. Nature 1988;331:356-8.